Suppr超能文献

阿昔洛韦在用于门诊胃肠外抗菌治疗的弹性输液装置中的稳定性评估。

Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy.

作者信息

Sime Fekade Bruck, Wallis Steven, Jamieson Conor, Hills Tim, Gilchrist Mark, Santillo Mark, Seaton R Andrew, Drummond Felicity, Roberts Jason

机构信息

University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia

University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.

出版信息

Eur J Hosp Pharm. 2025 Apr 23;32(3):272-277. doi: 10.1136/ejhpharm-2023-003784.

Abstract

OBJECTIVES

To investigate the stability of aciclovir solutions in elastomeric devices used for outpatient parenteral antimicrobial therapy (OPAT).

METHODS

Triplicates of two elastomeric devices, Accufuser and Easypump II, were filled with a solution of 200 mg, 2400 mg, and 4500 mg aciclovir in 240 mL 0.9% w/v saline. Devices were stored at room temperature for 14 days, followed by 24 hours storage at 32°C. Assessment using a stability indicating assay, pH and subvisible particle analysis was undertaken at 11 time points throughout the study.

RESULTS

Aciclovir solution at 200 mg and 2400 mg in 240 mL was stable for 14 days at room temperature (<20°C) and 24 hours of 32°C 'in-use' temperature exposure, remaining above the 95% limit for NHS stability protocols. The high dose was also stable for 14 days at room temperature, but when stored at 32°C there was precipitation of aciclovir within 4 hours in both devices. The precipitate was confirmed as aciclovir and precipitation was not a sign of chemical degradation.

CONCLUSIONS

Aciclovir concentrations above 2400 mg/240 mL are liable to precipitation and cannot be recommended for OPAT services because of heightened risks of nephrotoxicity. Aciclovir solution can be given as a continuous 24-hour infusion for OPAT services at a concentration range of 200-2400 mg in 240 mL in Accufuser and Easypump II elastomeric devices following 14 days storage at room temperature, protected from light.

摘要

目的

研究阿昔洛韦溶液在用于门诊胃肠外抗菌治疗(OPAT)的弹性装置中的稳定性。

方法

将两个弹性装置Accufuser和Easypump II各取三份,分别装入含200mg、2400mg和4500mg阿昔洛韦的240mL 0.9%(w/v)生理盐水溶液。装置在室温下储存14天,随后在32°C下储存24小时。在整个研究过程中的11个时间点进行稳定性指示分析、pH值和亚可见颗粒分析评估。

结果

240mL中含200mg和2400mg阿昔洛韦的溶液在室温(<20°C)下稳定14天,在32°C“使用中”温度下暴露24小时,仍高于英国国家医疗服务体系(NHS)稳定性协议的95%限值。高剂量溶液在室温下也稳定14天,但在32°C储存时,两种装置中的阿昔洛韦在4小时内均出现沉淀。沉淀物经确认是阿昔洛韦,沉淀并非化学降解的迹象。

结论

阿昔洛韦浓度高于2400mg/240mL时容易沉淀,由于肾毒性风险增加,不推荐用于OPAT服务。在Accufuser和Easypump II弹性装置中,阿昔洛韦溶液在室温下避光储存14天后,可在240mL中以200 - 2400mg的浓度范围进行连续24小时输注用于OPAT服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3f5/12128774/e7137b3341ce/ejhpharm-32-3-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验